Literature DB >> 30066596

Are neurofilaments valuable biomarkers for long-term disease prognostication in MS?

Michael Khalil1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30066596     DOI： 10.1177/1352458518791518

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  6 in total

1.  Acute Neurofilament Light Chain Plasma Levels Correlate With Stroke Severity and Clinical Outcome in Ischemic Stroke Patients.

Authors:  Helle H Nielsen; Catarina B Soares; Sofie S Høgedal; Jonna S Madsen; Rikke B Hansen; Alex A Christensen; Charlotte Madsen; Bettina H Clausen; Lars Henrik Frich; Matilda Degn; Christian Sibbersen; Kate L Lambertsen
Journal:  Front Neurol       Date:  2020-06-11       Impact factor: 4.003

2.  Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis.

Authors:  Mattia Rosso; Cindy T Gonzalez; Brian C Healy; Shrishti Saxena; Anu Paul; Kjetil Bjornevik; Jens Kuhle; Pascal Benkert; David Leppert; Charles Guttmann; Rohit Bakshi; Howard L Weiner; Tanuja Chitnis
Journal:  Ann Clin Transl Neurol       Date:  2020-05-25       Impact factor: 4.511

3.  Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS.

Authors:  Katja Akgün; Nicole Kretschmann; Rocco Haase; Undine Proschmann; Hagen H Kitzler; Heinz Reichmann; Tjalf Ziemssen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-04-08

Review 4.  Molecular biomarkers in multiple sclerosis.

Authors:  Tjalf Ziemssen; Katja Akgün; Wolfgang Brück
Journal:  J Neuroinflammation       Date:  2019-12-23       Impact factor: 8.322

Review 5.  Neurodegeneration and convergent factors contributing to the deterioration of the cytoskeleton in Alzheimer's disease, cerebral ischemia and multiple sclerosis (Review).

Authors:  Johanna Andrea Gutiérrez-Vargas; John Fredy Castro-Álvarez; Jose Fernando Zapata-Berruecos; Komal Abdul-Rahim; Anibal Arteaga-Noriega
Journal:  Biomed Rep       Date:  2022-02-18

6.  Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study.

Authors:  Ingrid Anne Lie; Sezgi Kaçar; Kristin Wesnes; Iman Brouwer; Silje S Kvistad; Stig Wergeland; Trygve Holmøy; Rune Midgard; Alla Bru; Astrid Edland; Randi Eikeland; Sonia Gosal; Hanne F Harbo; Grethe Kleveland; Yvonne S Sørenes; Nina Øksendal; Kristin N Varhaug; Christian A Vedeler; Frederik Barkhof; Charlotte E Teunissen; Lars Bø; Øivind Torkildsen; Kjell-Morten Myhr; Hugo Vrenken
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-06-01       Impact factor: 13.654
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.